FSPM (Fusion Pharm) Debt-to-Equity : 0.00 (As of . 20)

View and export this data going back to . Start your Free Trial

What is Fusion Pharm Debt-to-Equity?

Fusion Pharm's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was $0.00 Mil. Fusion Pharm's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was $0.00 Mil. Fusion Pharm's Total Stockholders Equity for the quarter that ended in . 20 was $0.00 Mil.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Fusion Pharm's Debt-to-Equity or its related term are showing as below:

FSPM's Debt-to-Equity is not ranked ^*
in the Healthcare Providers & Services industry.
Industry Median: 0.485
* Ranked among companies with meaningful Debt-to-Equity only.

Fusion Pharm Debt-to-Equity Historical Data

The historical data trend for Fusion Pharm's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fusion Pharm Debt-to-Equity Chart

Fusion Pharm Annual Data

Trend

Debt-to-Equity

Fusion Pharm Quarterly Data

Debt-to-Equity

Competitive Comparison of Fusion Pharm's Debt-to-Equity

For the Pharmaceutical Retailers subindustry, Fusion Pharm's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fusion Pharm's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fusion Pharm's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Fusion Pharm's Debt-to-Equity falls into.

Fusion Pharm Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Fusion Pharm's Debt to Equity Ratio for the fiscal year that ended in . 20 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(	+	)	/	N/A
	=	N/A

Fusion Pharm's Debt to Equity Ratio for the quarter that ended in . 20 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(	+	)	/
	=	N/A

Fusion Pharm (OTCPK:FSPM) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Fusion Pharm Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Fusion Pharm's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Fusion Pharm Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fusion Pharm Inc (OTCPK:FSPM) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

5850 East 58th Avenue, Unit F, Commerce City, CO, USA, 80022

Website

http://www.fusionpharminc.com

Fusion Pharm Inc is engaged in commercializing its patent pending PharmPods line of hydroponic cultivation systems. Its PharmPods are used for agricultural cultivation by urban farming companies and other specialty growers. Pharmpods are constructed of standard ISO steel shipping containers that are repurposed for use in indoor plant cultivation.

Fusion Pharm Headlines

No Headlines